Skip to main content

Headlines

Under Armour Sharpens Product Focus as Brand Transformation Advances
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
ADS-TEC H1 Loss Widens, Operating Loss Narrows; Advances Gigawatt-Scale Storage Project
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
AppFolio (APPF) Advances While Market Declines: Some Information for Investors
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Sweetgreen, Inc. (SG) Advances While Market Declines: Some Information for Investors
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Avacta H1 Loss Widens As AVA6103 Advances Toward 2027 Data
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Trump’s Third Surgeon General Pick Advances to Full Senate Vote
posted:
by: Bloomberg Politics
#channels:: #All, #Business, #Bloomberg, #BloombergPolitics, #Politics
Jade Biosciences Advances JADE301 Toward Phase 1 Trial In Dermatomyositis
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
China Repo Push Advances as Legal Issues, Low Yields Drag
posted:
by: Bloomberg Daybreak
#channels:: #All, #Business, #Bloomberg, #BloombergDaybreak, #Stocks
Lyft (LYFT) Advances While Market Declines: Some Information for Investors
posted:
by: Nasdaq Technology
#channels:: #All, #Business, #Nasdaq, #Technology, #NasdaqTechnology, #Stocks
Enterprise AI Advances Power Microsoft: Is There More Upside Ahead?
posted:
by: Nasdaq MSFT MicroSoft
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #MSFT, #MicroSoft
US Gold Eyes CK Gold Financing as Shovel-Ready Wyoming Mine Advances
posted:
by: Nasdaq Options
#channels:: #All, #Business, #Stocks, #Nasdaq, #Options, #StockOptions, #NasdaqOptions
Silexion Advances SIL204 With Positive Findings On Systemic Uptake In KRAS-Driven Cancers
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
CervoMed Advances Neflamapimod With New Tablet Formulation And FDA Dose Flexibility
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Addex Therapeutics H1 Net Loss Widens, Operating Loss Narrows; Advances GABAB PAM Cough Program
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
OSE Immunotherapeutics Highlights Pipeline Progress As Phase 3 Tedopi Study Advances
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks